Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

3 Biotech Stocks to Buy in April

TheMotleyFool

0 0

3 Biotech Stocks to Buy in AprilPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

Biotech stocks, in general, again performed dismally in the first quarter of 2022. However, there are some signs of improvement. The lower valuations could present a great buying opportunity once the inevitable strong rebound materializes.

We asked three Motley Fool contributors which biotech stocks they think are good picks to buy in April. Here's why they chose Amgen (NASDAQ: AMGN), Jazz Pharmaceuticals (NASDAQ: JAZZ), and Novocure (NASDAQ: NVCR).

Image source: Getty Images.

Source Fool.com

Like: 0

AMGN

Teilen